Keyphrases
Statins
100%
Hypertension Incidence
100%
Tenofovir Disoproxil Fumarate
100%
HIV Pre-exposure Prophylaxis
100%
Pre-exposure Prophylaxis (PrEP)
56%
Risk Difference
31%
Odds Ratio
25%
Incident Hypertension
25%
Hypertension
12%
Blood Pressure
12%
Kaiser Permanente
12%
Southern California
12%
Propensity Score Matching
12%
Data Matching
12%
Baseline Covariates
12%
Non-Hispanic White
6%
HIV Infection
6%
Electronic Health Records
6%
Health Plans
6%
Adult Age
6%
Cardiometabolic Health
6%
Retrospective Cohort Study
6%
Multiple Imputation
6%
Blood Lipids
6%
Logistic Regression
6%
Pharmacy Records
6%
Subgroup Analysis
6%
Statin Use
6%
Used Electronics
6%
Match Analysis
6%
G-computation
6%
Outpatient Pharmacy
6%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Tenofovir Alafenamide
100%
Statin (Protein)
63%
Tenofovir Disoproxil
45%
Cohort Study
9%
Human Immunodeficiency Virus Infection
9%